Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roberta, Formato"'
Autor:
Gridelli C., Gallo C., Morabito A., Iaffaioli R. V., Favaretto A., Isa L., Barbera S., Gamucci T., Ceribelli A., Filipazzi V., Maione P., Rossi A., Barletta E., Signoriello S., De Maio E., Piccirillo M. C., Di Maio M., Rocco G., Vecchione A., Perrone F., Cesare Gridelli, Paolo Maione, Antonio Rossi, Ciro Gallo, Giuseppe Signoriello, Paolo Chiodini, Simona Signoriello, Francesco Perrone, Massimo Di Maio, Maria Carmela Piccirillo, Ermelinda De Maio, Jane Bryce, Alessandro Morabito, Raffaele Costanzo, Gaetano Rocco, Rosario Vincenzo Iaffaioli, Emiddio Barletta, Roberta Formato, Aldo Vecchione, Adolfo Favaretto, Giulia Pasello, Cristina Magro, Luciano Isa, Raffaele Venezia, Mario Comandè, Santi Barbera, Francesco Renda, Antonio Volpintesta, Teresa Gamucci, Maria Anna Giampaolo, Giovanni Mansueto, Anna Ceribelli, Ilaria Carbone, Domenica Pellegrini, Virginio Filipazzi, Elena Piazza, Sabrina Ferrario, Vittorina Zagonel, Giuditta di Isernia, Marco Ciaparrone, Francovito Piantedosi, Fabiana Vitiello, Nicolò Borsellino, Maria Elia Vitale, Luigi Brancaccio, Sergio Spina, Maria Rosaria Valerio, Raffaella Felletti, Salvatore Tafuto, Marianna Giampaglia, Rita Migliorino, Francesco Rosetti, Francesco Carrozza, Nestore Rossi, Mario Spatafora, Manlio Mencoboni, Ernest Marshall
Introduction: Treatment of elderly patients with small cell lung cancer (SCLC) is based on scanty evidence. Methods: Patients with extensive SCLC, age >70 years, and performance status 0-2 were eligible for a study looking for optimal two-drug combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c287ad1d0d718db86daca9f97723eed4
http://hdl.handle.net/2318/150674
http://hdl.handle.net/2318/150674
Autor:
Giuseppe Di Lorenzo, Roberta Formato, Giuseppe Grimaldi, Beniamino Casale, Clementina Savastano, Luigi De Lucia, Giacomo Cartenì, Gaetano Facchini, Mimma Rizzo, Luigi Maiorino, Antonio Febbraro
Publikováno v:
Future oncology (London, England). 11(2)
ABSTRACT Aims: This study, conducted in a ‘field-practice’ scenario, investigates the effectiveness and safety of everolimus in the second-line treatment of metastatic renal cell carcinoma (mRCC) patients. Patients & methods: mRCC patients, who s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5de0abca0491a2718f441bad334e5be
https://pubmed.ncbi.nlm.nih.gov/25078333
https://pubmed.ncbi.nlm.nih.gov/25078333
Autor:
Emiddio, Barletta, Francesco, Fiore, Bruno, Daniele, Alessandro, Ottaiano, Roberto, D'Angelo, Ettore, Ferrari, Roberta, Formato, Anna, Tortoriello, Giacinto, Turitto, Giovanni Salvatore, Bruni, Sandro, Pignata, Rosario Vincenzo, Iaffaioli
Publikováno v:
Frontiers in bioscience : a journal and virtual library. 11
The present study was conducted to evaluate activity and toxicity of the FLEC (folinic acid 100 mg/m2; 5-fluorouracil 1000 mg/m2; carboplatin 300 mg/m2; epirubicin 60 mg/m2) schedule as second-line treatment for progressive locally advanced or metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc1fceb2a47ea093d1eea6c907660d4e
https://pubmed.ncbi.nlm.nih.gov/16146770
https://pubmed.ncbi.nlm.nih.gov/16146770
Autor:
Carmela, Pisano, Stefano, Greggi, Rosa, Tambaro, Simona, Losito, Francesco, Iodice, Massimo, Di Maio, Ettore, Ferrari, Marzia, Falanga, Roberta, Formato, Vincenzo Rosario, Iaffaioli, Sandro, Pignata
Publikováno v:
Anticancer research. 25(5)
Mucinous ovarian carcinoma has a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of first-line and second-line chemotherapy in patients with mucinous ovarian cancer in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bfe74a3e50fe44c3d85073169de0bec1
https://pubmed.ncbi.nlm.nih.gov/16101169
https://pubmed.ncbi.nlm.nih.gov/16101169
Publikováno v:
Current Opinion in Oncology; May2005, Vol. 17 Issue 3, p212-217, 6p